In ER+ breast cancer cell lines (MCF-7, BT-474 and T47D), OC inhibited proliferation in cells treated with 17-β-estradiol, decreasing ERα expression in BT-474 cells both in vitro and in vivo [158]. The gene discussed is ESR1; the disease is breast cancer.